Efectividad y seguridad del corticosteroide nasal mometasona como tratamiento de rinosinusitis crónica sin pólipos

Yepes Núñez, Juan José; Flórez Gómez, Iván D; Vanegas Escamilla, Egdda Patricia; Caballero, María Camila; Rengifo, Angélica María; García, Tania Marcela.
Bogotá; IETS; dic. 2014. 37 p. ilus.
Monografía en Español | BRISA, LILACS | ID: biblio-847177

Documentos relacionados

  1. Different types of intranasal steroids for chronic rhinosinusitis.
  2. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
  3. Local corticosteroids, why are they not used more / properly ?
  4. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
  5. Using intranasal corticosteroids.
  6. Comparison of Histopathological Effects of Thymoquinone and Local Nasal Corticosteroids in Allergic Rhinitis in a Rabbit Model.
  7. Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.
  8. Efficacy of montelukast for adenoid hypertrophy in paediatrics: A systematic review and meta-analysis.
  9. A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
  10. The relevance of the Mometasone furoate nasal spray in clinical practice.